EyePoint (EYPT) Operating Expenses (2010 - 2026)
EyePoint (EYPT) posted Operating Expenses of $5.0 million for Q1 2026, down 98.11% sequentially from $262.7 million in Q4 2025, and up 10.3% YoY from $4.5 million in Q1 2025.
EyePoint (EYPT) Operating Expenses (2010 - 2026) Analysis & Trends
EyePoint has reported Operating Expenses for 17 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Operating Expenses rose 10.3% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $339.3 million (up 396.0% YoY) and the FY2025 annual result came in at $274.8 million, up 45.3% from the prior year.
- Operating Expenses eased to $5.0 million in Q1 2026 per EYPT's latest filing, from $262.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $262.7 million in Q4 2025 and troughed at -$72.5 million in Q4 2023.
- A 5-year average of $36.0 million and a median of $29.2 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses sank 233.65% in 2023, then soared 1779.8% in 2025.
- Over 5 years, Operating Expenses stood at $54.3 million in 2022, then tumbled by 233.65% to -$72.5 million in 2023, then surged by 178.35% to $56.8 million in 2024, then soared by 362.33% to $262.7 million in 2025, then sank by 98.11% to $5.0 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $5.0 million, $262.7 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | 97.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97.89 Mn |
| Mar 31, 2026 | 4.96 Mn |
| Dec 31, 2025 | 262.73 Mn |
| Sep 30, 2025 | 4.01 Mn |
| Jun 30, 2025 | 67.56 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 56.83 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.59 Mn |
| Mar 31, 2024 | 45.01 Mn |
| Dec 31, 2023 | -72.53 Mn |
| Sep 30, 2023 | 29.60 Mn |
| Jun 30, 2023 | 31.87 Mn |
| Mar 31, 2023 | 29.24 Mn |
| Dec 31, 2022 | 54.27 Mn |
| Sep 30, 2022 | 28.41 Mn |
| Jun 30, 2022 | 30.78 Mn |
| Mar 31, 2022 | 27.58 Mn |
| Dec 31, 2021 | 29.59 Mn |
| Sep 30, 2021 | 24.37 Mn |